BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27479926)

  • 1. "Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study.
    Lopez D; Luque-Fernandez MA; Steele A; Adler GK; Turchin A; Vaidya A
    Ann Intern Med; 2016 Oct; 165(8):533-542. PubMed ID: 27479926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study.
    Prete A; Subramanian A; Bancos I; Chortis V; Tsagarakis S; Lang K; Macech M; Delivanis DA; Pupovac ID; Reimondo G; Marina LV; Deutschbein T; Balomenaki M; O'Reilly MW; Gilligan LC; Jenkinson C; Bednarczuk T; Zhang CD; Dusek T; Diamantopoulos A; Asia M; Kondracka A; Li D; Masjkur JR; Quinkler M; Ueland GÅ; Dennedy MC; Beuschlein F; Tabarin A; Fassnacht M; Ivović M; Terzolo M; Kastelan D; Young WF; Manolopoulos KN; Ambroziak U; Vassiliadi DA; Taylor AE; Sitch AJ; Nirantharakumar K; Arlt W; ;
    Ann Intern Med; 2022 Mar; 175(3):325-334. PubMed ID: 34978855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Incidence of Fractures in Patients With Nonfunctional Adrenal Tumors.
    Lindh JD; Patrova J; Mannheimer B; Falhammar H
    JAMA Netw Open; 2024 Apr; 7(4):e246453. PubMed ID: 38619841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History of Adrenal Incidentalomas With and Without Mild Autonomous Cortisol Excess: A Systematic Review and Meta-analysis.
    Elhassan YS; Alahdab F; Prete A; Delivanis DA; Khanna A; Prokop L; Murad MH; O'Reilly MW; Arlt W; Bancos I
    Ann Intern Med; 2019 Jul; 171(2):107-116. PubMed ID: 31234202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
    Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
    Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes.
    Wang T; Lu J; Su Q; Chen Y; Bi Y; Mu Y; Chen L; Hu R; Tang X; Yu X; Li M; Xu M; Xu Y; Zhao Z; Yan L; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Shi L; Ning G; Zhao J; Wang W;
    JAMA Cardiol; 2019 Sep; 4(9):874-883. PubMed ID: 31365039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of combined healthy lifestyle with risk of adverse outcomes in patients with prediabetes.
    Xu X; Li J; Yu Y; Tan X; Xu F; Wang B; Wang N; Lu Y
    Diabetes Metab Res Rev; 2024 May; 40(4):e3795. PubMed ID: 38546142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study.
    Papademetriou V; Nylen ES; Doumas M; Probstfield J; Mann JFE; Gilbert RE; Gerstein HC
    Am J Med; 2017 Dec; 130(12):1465.e27-1465.e39. PubMed ID: 28842165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative Risk of Cardiovascular Disease Is Higher in Women With Type 2 Diabetes, but Not in Those With Prediabetes, as Compared With Men.
    Succurro E; Fiorentino TV; Miceli S; Perticone M; Sciacqua A; Andreozzi F; Sesti G
    Diabetes Care; 2020 Dec; 43(12):3070-3078. PubMed ID: 32998991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors.
    Favero V; Aresta C; Parazzoli C; Cairoli E; Eller-Vainicher C; Palmieri S; Salcuni AS; Arosio M; Persani L; Scillitani A; Morelli V; Chiodini I
    Cardiovasc Diabetol; 2023 May; 22(1):102. PubMed ID: 37131218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience.
    Comlekci A; Yener S; Ertilav S; Secil M; Akinci B; Demir T; Kebapcilar L; Bayraktar F; Yesil S; Eraslan S
    Endocrine; 2010 Feb; 37(1):40-6. PubMed ID: 19882253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the risks of benign adrenocortical incidentalomas.
    Di Dalmazi G
    Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):193-199. PubMed ID: 28248753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations among sleep disturbances, nocturnal sleep duration, daytime napping, and incident prediabetes and type 2 diabetes: the Heinz Nixdorf Recall Study.
    Kowall B; Lehnich AT; Strucksberg KH; Führer D; Erbel R; Jankovic N; Moebus S; Jöckel KH; Stang A
    Sleep Med; 2016 May; 21():35-41. PubMed ID: 27448469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
    Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma.
    Fernández-Real JM; Engel WR; Simó R; Salinas I; Webb SM
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):53-61. PubMed ID: 9797847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
    Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
    Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of new recommendations for adrenal incidentalomas in the evaluation of excessive cortisol secretion and follow-up.
    Ruiz A; Michalopoulou T; Megia A; Näf S; Simón-Muela I; Solano E; Martínez L; Vendrell J
    Eur J Clin Invest; 2019 Feb; 49(2):e13048. PubMed ID: 30412278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
    Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
    Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.